Search results
ACC 2026 Late-Breaking Science Collection
Video Series
Author(s):
Nicolas M Van Mieghem
Added:
5 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for…
View more
AF Symposium 2026 Late-Breaking Science Collection
Video Series
TCT 2025 Late-Breaking Science Collection
Video Series
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
1 year ago
Keep up-to-date with our video collection covering the American Heart Association's 2024 Scientific Sessions in Chicago. For expert insights on the hottest late-breaking and featured science trials, tune in to our collection.To catch reviews on the most awaited trials, watch our recurring series View From the ThoraxCenter, hosted by Prof Nicolas Van Mieghem andDr Joost Daemen (Thoraxcenter,…
View more
ADA 2025 Late-Breaking Science Collection
Video Series
HFA 24: Late-Breaking Science Video Collection
Video Series
NY Valves 2025 Late-Breaking Science Collection
Video Series
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
11 months ago
Dive into our collection covering the hot line and late-breaking trials presented at EuroPCR 2025. Reviewing the sessions you don't want to miss, interventional experts Prof Nicolas Van MieghemandDr Joost Daemen will be leading our regular series View From the Thoraxcenter. For a deeper dive into the most anticipated trials, our Expert Interviews have you covered.
View more
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more